Baird Financial Group
NTUS

Baird Financial Group’s Natus Medical Inc NTUS Stock Holding History

Baird Financial Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,504
Closed -$410K – 1886
2022
Q2 		$410K Sell
12,504
-19,959
-61% -$631K ﹤0.01% 1419
2022
Q1 		$853K Buy
32,463
+19,492
+150% +$476K ﹤0.01% 1218
2021
Q4 		$308K Buy
12,971
+1,265
+11% +$31.2K ﹤0.01% 1656
2021
Q3 		$294K Buy
11,706
+1,785
+18% +$45.5K ﹤0.01% 1675
2021
Q2 		$258K Buy
9,921
+212
+2% +$5.77K ﹤0.01% 1613
2021
Q1 		$249K Buy
+9,709
New +$249K ﹤0.01% 1579

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Baird Financial Group's NTUS Position: Q3 2022 in Review

Baird Financial Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 12,504 shares — an estimated $410K sold.

Baird Financial Group first reported a position in NTUS in Q1 2021 and held it in 6 quarters. The position peaked at $853K in Q1 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Baird Financial Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 12,504 Natus Medical Inc shares in Q3 2022, an estimated $410K.
  • Baird Financial Group first reported a position in Natus Medical Inc in Q1 2021 and held it in 6 quarters.
  • Baird Financial Group's Natus Medical Inc position peaked at $853K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.